|
|
|
0 members (),
2,222
guests, and
23
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
|
There are no members with birthdays on this day. |
#386187
Sat 23 Jul 2016 01:22:AM
|
Joined: Feb 2001
Posts: 381,904
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,904 |
Researchers found that treating metastatic thyroid cancer patients harboring a BRAF mutation with the targeted therapy vemurafenib -- originally approved for melanoma patients with the mutation -- showed promising anti-tumor activity in a third of patients. Source: Drug targeting BRAF mutation slows thyroid cancer, too
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Entire Thread
|
Drug targeting BRAF mutation slows thyroid cancer, too
|
Webmaster
|
Sat 23 Jul 2016 01:22:AM
|
|
Forums60
Topics762,137
Posts796,866
Members2,957
| |
Most Online17,963
Jan 15th, 2026
|
|
|
|
|
Copyright 1996 - 2026 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under the agreement, to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and e-mail lists of AUS-CITY are distributed with permission from DoD/USSTRATCOM.
Reprise Hosting
|
|
